Svetlana S Efimova Selected Research

Anti-Bacterial Agents (Antibiotics)

12/2023	Lipid-Centric Approaches in Combating Infectious Diseases: Antibacterials, Antifungals and Antivirals with Lipid-Associated Mechanisms of Action.
7/2023	Triggering the Amphotericin B Pore-Forming Activity by Phytochemicals.
10/2022	Lipid Microenvironment Modulates the Pore-Forming Ability of Polymyxin B.
10/2014	Direct visualization of solid ordered domains induced by polyene antibiotics in giant unilamellar vesicles.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Svetlana S Efimova Research Topics

Disease

3	Mycoses (Diseases, Fungus) 07/2023 - 10/2014
1	Communicable Diseases (Infectious Diseases) 12/2023
1	Candidemia 01/2023
1	COVID-19 01/2023
1	Infections 10/2022
1	Carcinoma (Carcinomatosis) 10/2021
1	Neuroblastoma 09/2020
1	Protozoan Infections 01/2020
1	Invasive Fungal Infections 01/2020
1	Candidiasis (Moniliasis) 06/2018
1	Rupture 10/2010

Drug/Important Bio-Agent (IBA)

4	Anti-Bacterial Agents (Antibiotics)IBA 12/2023 - 10/2014
3	Amphotericin B (Amphotericin)FDA LinkGeneric 07/2023 - 01/2020
2	LipidsIBA 12/2023 - 01/2023
2	Nystatin (Mycostatin)FDA LinkGeneric 01/2020 - 06/2018
1	Antiviral Agents (Antivirals)IBA 12/2023
1	MacrolidesIBA 07/2023
1	AlkaloidsIBA 01/2023
1	AmidesIBA 01/2023
1	Antifungal AgentsIBA 01/2023
1	Natamycin (Pimaricin)FDA Link 01/2023
1	LipopolysaccharidesIBA 10/2022
1	Phospholipids (Phosphatides)FDA LinkGeneric 10/2022
1	Polymyxin B (Aerosporin)FDA LinkGeneric 10/2022
1	MetalsIBA 10/2021
1	PorphyrinsIBA 10/2021
1	echinenoneIBA 09/2020
1	Antimycin AIBA 09/2020
1	syringomycin EIBA 01/2020
1	fengycinIBA 01/2020
1	Artificial Membranes (Artificial Membrane)IBA 10/2010
1	Peptides (Polypeptides)IBA 10/2010

Therapy/Procedure

2	Therapeutics 01/2020 - 06/2018